Aurobindo Pharma names Dr Sanjay Chaturvedi as CEO of subsidiary
08 April 2023 | News
Aurobindo has transferred its antibiotic API division to Apitoria Pharma
Dr Sanjay Chaturvedi has been appointed as the Chief Executive Officer (CEO) of Apitoria Pharma, a wholly owned subsidiary of Hyderabad-based Aurobindo Pharma.
Chaturvedi is an accomplished leader with close to three decades of rich experience in various prestigious organisations. His proven success of creating and growing organisations demonstrates his commitment to strategy and transformative excellence. Prior to this role, he was associated with IOL Chemicals and Pharma as Executive Director & CEO. He has also worked as the President at Praj Industries.
He has earlier worked with Aurobindo Pharma from 2013 to 2015 as the Senior Vice President. Chaturvedi has also gained experience working as the Vice President and Global Head - Sales and Marketing at Dr. Reddy's Laboratories.
